Effective medicines regulation protect and improve the health of millions of people every day Dr Olexandr Polishchuk World Health Organization Regional.

Slides:



Advertisements
Similar presentations
Regional priority goal II Prevent and substantially reduce health consequences from accidents and injuries and pursue a decrease in morbidity from lack.
Advertisements

Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
WHO STRATEGY FOR WORKING WITH COUNTRIES:REGIONAL AND COUNTRY PERSPECTIVE TECHNICAL BRIEFING SEMINAR,Geneva,19-23 September 2005 Dr. Jean-Marie TRAPSIDA.
Group 3 Irrational use of Medicine and medical technology.
Presentation by Cambodian Participants Phuket, Thailand February 2012 Health Impact Assessment Royal Government of Cambodia.
Prevention of Childhood Obesity Joining forces… Caroline Bollars Technical Officer, Nutrition Policy Nutrition, Physical Activity and Obesity World Health.
Panamerican Health Organization 1 James Fitzgerald Senior Advisor, Medicines and Health Technologies PAHO/WHO Washington Affordable, Appropriate Access.
European Heart Health Charter Official Launch 12 June 2007 European Parliament - Brussels "Every child born in the new millennium has the right to live.
The CEE Bankwatch Network's mission is to prevent the environmentally and socially harmful impacts of international development finance, and to promote.
Technical Briefing Seminar, WHO Headquarters, September WHO Traditional Medicine Strategy Dr Samvel Azatyan Traditional Medicine (TRM) Department.
Entrenching the KNH Formulary to Clinical Practice DR WK SIGILAI MTC CHAIR.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Essential Medicines Programmes Sudan now Essential Medicines Programmes Sudan now.
WHO Traditional Medicine Strategy and Guidelines Dr Arvind Mathur MD, DHA, DNB Cluster Coordinator Family & Community Health WHO-India World Health Organisation.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
National Medicine Policy
046:127 Pharmaceutical Management for Underserved Populations  Paper on Current Controversy  Team Assignment: Observational Visits  National Drug Policy/Assessment.
Child and Adolescent Health and Development RHR RHR Guidance of WHO on safe abortion FIAPAC, Moscow October 28, 2005 G. Lazdane Regional Adviser RHR WHO.
The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa 2, 1 Ministry of Health, 2 Pharmacy School, Health.
Margarit MELIKYAN Drug Utilization Research Group PO, Armenia, National Institute of Health Access to and Use of Medicines by Households in Armenia: Impact.
Tanzania1. 2 Tanzania Assessment Gabriel Upunda Tanzania3 DemographicsTanzania Area (sq km)945,100 Population 32,900,000 25% urban GNP per capitaUS $240.
Patient safety panel Magdalena Machalska EPF Policy Assistant.
ACCESS TO MEDICINES - POLICY AND ISSUES
1 Department of Medicines Policy and Standards, Health Technology and Pharmaceuticals WHO’s Role in Assuring the Quality Safety and Efficacy of Medicines:
Jordan Food & Drug Administration. Pharmaceutical Policy Studies Workshop RUD Unit Plan for RUD Unit.
ABSTRACT Title: Developing National Formularies Based on the WHO Model Formulary Authors: Tisocki K 3, Laing RL 1, Hogerzeil H 1, Mehta DK 2, Ryan RSM.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Fire Safety in European Hotels Dr SD Christian. Fire Safety in European Hotels Council Recommendation 86/666/EEC Fire Safety in European Hotels.
Working Group No. 5 “ Occupational Safety & Health ” Chair of the Working Group: H.E Mr. Md. Mujibul Haque, State Minister Government of Bangladesh.
SARPAM Southern African Regional Programme for Access to Medicines and Diagnostics Presentation to Botswana TRIPS and Access to Medicines workshop 26 March.
Training course on the Pharmacovigilance of antiretroviral medicines 23 – 28 November 2009 Rationale, Objectives and Expected Outcomes.
Juanita Folmsbee, Country Project Director, SIAPS program Feedback related to Pharmaceutical Sector.
1 Vision: To be an agency producing outputs that contribute to optimal efficiency of the Indonesian Universal Health Coverage (UHC) Mission: To ensure.
WHO Regional Workshop on Good Manufacturing Practices for Blood Establishments Dr Ana Padilla, Blood Products & related Biologicals Essential Medicines.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.
EPHA Presentation Healthcare and social services treated equally as estate agents or advertising companies excluded from the Directive or Healthcare and.
2010 James Fitzgerald Senior Advisor, Medicines and Health Technologies PAHO/WHO rd St Washington DC USA International Cooperation in Quality.
Implementation of PANDRH Guidelines NAFTA Region VI PANDRH Conference Brasilia, July 2-8, 2011 Justina Molzon -- US Food and Drug Administration Mike Ward.
Round Table: Future challenges for PANDRH CARICOM Perspective.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
WHO Estonia country office Marge Reinap Head of WHO Country Office in Estonia.
Coordination of health care in the EU Jakub Wtorek European Commission Directorate General for Employment, Social Affairs and Inclusion Unit: Active Ageing,
How to get involved in VICH Dr. Allen Bryce Independent consultant Canberra, Australia VICH Workshop: Dar Es Salaam, Tanzania – 24.
1 The contribution of VICH to the global One Health approach VICH5 CONFERENCE, OCTOBER 2015, TOKYO Jean-Pierre Orand, Anses, France, OIE Collaborating.
Dr Charmaine Gauci Superintendent of Public Health/Director General PH
Anne-Marie Yazbeck, PhD National Infoday, Sweden 2017
Benjamin Nyakutsey Head, Policy Unit PPMED, Ghana Ministry of Health
Normative work and capacity building in Penitentiary system
Promoting Drug and Therapeutics Committees in the Developing World
Program Proposals.
SUNARTONO HEAD OF SLEMAN DISTRICT HEALTH OFFICE, INDONESIA
Richard Laing EMP/WHO TBS 2012
Dr. Gabriella Pall for the European Child Safety Alliance, EuroSafe
Minimum income schemes in Europe: The EU context
Vision, Mission, and Goals
Network Director European Health Futures Forum
‘universal health coverage for all’
funding opportunities for environment and nature conservation
National Medicines Policies
Issues on Dispensing Dr Percy Mahlathi.
Richard Laing WHO/PAU TBS 2013
Access to Essential Medicines
Access to Essential Medicines
Interventions in the Kosovo Pharmaceutical Sector: Success or Failure?
Outline Background: development of the Commission’s position
Pharmacy Sector SECTOR COMMITMENT TO END TB
Evaluation of the Jaspers initiative
National Medicines Policies
Presentation transcript:

Effective medicines regulation protect and improve the health of millions of people every day Dr Olexandr Polishchuk World Health Organization Regional Office for Europe

Draft strategy evaluation (1) Focus of this presentation – pharmaceutical sector It covers only the approach to liberalization of the market and this seams to be considered as panacea.

Draft strategy evaluation (2) Health 2020 http://www.euro.who.int/en/health-topics/health-policy/health-2020-the-european-policy-for-health-and-well-being Health 2020 reconfirms the commitment of WHO and its Member States to ensure universal coverage, including access to high-quality and affordable care and medicines. Medicines are essential for preventing and treating diseases, and poor-quality medicines represent a public health hazard.

Draft strategy evaluation (3) Rational selection and use of medicines EML, clinical protocols, formulary development and update Good prescribing practices Efficient pharmacovigilance system Promotion and advertisement of medicines

Proposals for draft strategy (1) Develop and implement national medicines strategy in line with Health 2020 and Strategy 2020 Ukraine Harmonize medicine’s legislation and regulations with EU norms, standards and practices, WHO guidelines and recommendations Continue capacity building using the existing networks (PIC/S, ICH, PPRI, EUnetHTA, etc)

Resolution В) Support in case of incorporation of substantial amendments (previous slide suggestions but not limited to);